Sarah Roberts, DrPH, is an Associate Professor at ANSIRH, at the University of California, San Francisco. She studies the ways that policies and the health care system punish, rather than support, structurally vulnerable pregnant women, including pregnant women using alcohol and drugs and pregnant women considering abortion. Dr. Roberts' current research focuses on evaluating state-level restrictive abortion policies and state-level policies targeting alcohol and drug use during pregnancy, and developing an evidence-base to inform a genuine public health approach to abortion. Dr. Roberts is also leading a project to engage public health professionals working in health departments in reflecting on abortion-related work in health departments and opportunities to align this work with accepted public health frameworks. Dr. Roberts has published more than 70-peer reviewed manuscripts and has received grant funding from multiple private foundations as well as the National Institutes of Health. Dr. Roberts' work has been published in JAMA, American Journal of Public Health, Maternal and Child Health Journal, and Alcohol and Alcoholism. Dr. Roberts received her undergraduate degree in history from Columbia University, her MPH and a Graduate Certificate in Women’s Studies from the University of Michigan, and her DrPH from the University of California, Berkeley.
February 6, 2021
Upadhyay UD, McCook AA, Bennett AH, Cartwright AF, Roberts SCM. State abortion policies and Medicaid coverage of abortion are associated with pregnancy outcomes among individuals seeking abortion recruited using Google Ads: A national cohort study. Social Science & Medicine. February 2021; [Epub ahead of print].
January 4, 2021
White K, Bhavik Kumar, Goyal V, Wallace RR, Roberts SCM, Grossman D. Changes in abortion in Texas following an executive order ban during the coronavirus pandemic. JAMA Internal Medicine. January 2021; 325(7):691-693.
December 1, 2020
Roberts SCM, Schroeder R, Joffe C. COVID-19 and independent abortion providers: Findings from a rapid-response survey. Perspectives on Sexual and Reproductive Health. December 2020; 52(4):217-225.
November 21, 2020
Upadhyay UD, Schroeder R, Roberts SCM. Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19. Contraception: X. November 2020; 2:100049.
August 5, 2020
Roberts SCM. Good intentions are not enough: truly supporting pregnant women with substance use disorders requires evaluating the impact of our policies and practices. Women's Reproductive Health. August 2020; 7:3,181-184.
July 1, 2020
Toquinto SM, Berglas NF, McLemore MR, Delgado A, Roberts SCM. Pregnant women's acceptability of alcohol, tobacco, and drug use screening and willingness to disclose use in prenatal care. Women's Health Issues. July 2020; 30(5):P345-352.